Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Nov 2021
Historique:
received: 20 10 2021
revised: 16 11 2021
accepted: 19 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 21 12 2021
Statut: epublish

Résumé

Preclinical, clinical, and epidemiological studies indicate that vitamin D3 (VD) deficiency is a risk factor for the development of breast cancer. Underlying mechanisms include the ability of calcitriol to induce cell differentiation, inhibit oncogenes expression, and modify different signaling pathways involved in the control of cell proliferation. In addition, calcitriol combined with different kinds of antineoplastic drugs has been demonstrated to enhance their beneficial effects in an additive or synergistic fashion. However, a recognized adjuvant regimen based on calcitriol for treating patients with breast cancer has not yet been fully established. Accordingly, in the present work, we review and discuss the preclinical and clinical studies about the combination of calcitriol with different oncological drugs, aiming to emphasize its main therapeutic benefits and opportunities for the treatment of this pathology.

Identifiants

pubmed: 34884550
pii: ijms222312741
doi: 10.3390/ijms222312741
pmc: PMC8657847
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Bone Density Conservation Agents 0
Calcitriol FXC9231JVH

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Consejo Nacional de Ciencia y Tecnología
ID : 256994
Organisme : Consejo Nacional de Ciencia y Tecnología
ID : A1-S-10749

Références

Cancers (Basel). 2021 Jul 16;13(14):
pubmed: 34298790
J Oncol. 2020 Mar 9;2020:9258396
pubmed: 32211045
Steroids. 2014 Jul;85:30-5
pubmed: 24747771
Stem Cell Res Ther. 2013;4(6):146
pubmed: 24331293
Anticancer Res. 2018 Sep;38(9):5043-5048
pubmed: 30194148
Semin Oncol Nurs. 2015 May;31(2):146-55
pubmed: 25951743
PLoS One. 2012;7(9):e45063
pubmed: 22984610
J Steroid Biochem Mol Biol. 1991 Oct;39(4A):455-60
pubmed: 1654997
Anticancer Res. 2018 Feb;38(2):1201-1207
pubmed: 29374758
J Pineal Res. 2014 Aug;57(1):120-9
pubmed: 24920214
Nutr Cancer. 2009;61(4):544-53
pubmed: 19838927
Br J Cancer. 2001 Mar 2;84(5):686-90
pubmed: 11237391
Am J Cancer Res. 2021 Dec 15;11(12):5951-5964
pubmed: 35018235
Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):
pubmed: 27599530
J Clin Pharmacol. 2019 Nov;59(11):1543-1550
pubmed: 31172521
Eur J Med Chem. 2020 Dec 1;207:112738
pubmed: 32829183
Breast Cancer Res Treat. 2001 May;67(2):157-68
pubmed: 11519864
Anticancer Res. 2015 Feb;35(2):1189-95
pubmed: 25667510
Int J Oncol. 1998 Sep;13(3):421-8
pubmed: 9683773
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):362-7
pubmed: 20412854
Int J Oncol. 2015 Oct;47(4):1266-72
pubmed: 26252842
Anticancer Res. 2006 Jul-Aug;26(4A):2749-53
pubmed: 16886687
Oncol Rep. 2004 Feb;11(2):441-6
pubmed: 14719081
Anticancer Res. 2012 Jan;32(1):359-65
pubmed: 22213327
N Engl J Med. 1998 Nov 26;339(22):1609-18
pubmed: 9828250
Cancer Treat Rev. 2014 Jul;40(6):739-49
pubmed: 24480385
Br J Cancer. 2004 Mar;90 Suppl 1:S2-6
pubmed: 15094757
Autophagy. 2012 May 1;8(5):739-53
pubmed: 22498493
Biochem Cell Biol. 1994 Nov-Dec;72(11-12):537-45
pubmed: 7654327
Life Sci. 2020 Jul 15;253:117733
pubmed: 32360127
Clin Cancer Res. 2001 Apr;7(4):971-6
pubmed: 11309348
Front Oncol. 2021 Apr 16;11:644134
pubmed: 33937049
Med Oncol. 2004;21(2):117-21
pubmed: 15299183
J Cancer Res Clin Oncol. 2017 Jul;143(7):1107-1122
pubmed: 28025696
Maturitas. 2015 Jan;80(1):52-7
pubmed: 25466304
Oncogene. 2002 Aug 12;21(35):5400-13
pubmed: 12154403
J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309
pubmed: 21743022
Curr Med Chem. 2010;17(36):4462-81
pubmed: 21062257
J Cell Mol Med. 2009 Aug;13(8B):2236-2252
pubmed: 18681906
Clin Nutr ESPEN. 2019 Apr;30:170-184
pubmed: 30904218
Prostate. 1993;22(4):335-45
pubmed: 8497428
Immunotherapy. 2017 Nov;9(14):1127-1131
pubmed: 29067883
Cancer Res. 1988 May 15;48(10):2734-9
pubmed: 2834048
Biomedicines. 2018 Jul 17;6(3):
pubmed: 30018256
Blood. 1998 Aug 1;92(3):996-1002
pubmed: 9680369
Adv Exp Med Biol. 2008;617:271-80
pubmed: 18497050
Endocrinology. 1990 Jul;127(1):39-45
pubmed: 2163320
In Vivo. 2021 May-Jun;35(3):1345-1354
pubmed: 33910812
J Biol Chem. 1995 Mar 24;270(12):6639-43
pubmed: 7896803
Cancer. 2004 May 1;100(9):1868-75
pubmed: 15112267
Chem Biol Interact. 2020 Jan 5;315:108865
pubmed: 31628941
J Natl Cancer Inst. 2008 May 7;100(9):672-9
pubmed: 18445819
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):708-11
pubmed: 17368188
J Clin Endocrinol Metab. 2020 Apr 1;105(4):
pubmed: 31841590
Mol Cell Endocrinol. 2001 Feb 14;172(1-2):69-78
pubmed: 11165041
Toxicol Appl Pharmacol. 2013 Nov 1;272(3):746-56
pubmed: 23921149
Front Endocrinol (Lausanne). 2012 Apr 23;3:58
pubmed: 22649423
Rev Assoc Med Bras (1992). 2019 Jun 03;65(5):699-705
pubmed: 31166448
J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):227-32
pubmed: 19429426
J Lab Autom. 2016 Dec;21(6):723-731
pubmed: 27325106
Mol Cell Biochem. 1998 Nov;188(1-2):13-20
pubmed: 9823006
Mol Med Rep. 2018 Apr;17(4):5581-5588
pubmed: 29436642
Cancer Chemother Pharmacol. 2005 Nov;56(5):492-6
pubmed: 15918041
Front Immunol. 2019 Jun 06;10:1307
pubmed: 31244851
BMC Cancer. 2014 Mar 29;14:230
pubmed: 24678876
J Endocrinol. 1994 Jun;141(3):555-63
pubmed: 8071654
Oncotarget. 2017 May 19;8(34):57782-57799
pubmed: 28915711
Breast Cancer Res Treat. 2004 May;85(1):53-63
pubmed: 15039597
NPJ Breast Cancer. 2020 Jun 12;6:22
pubmed: 32566743
Expert Opin Drug Metab Toxicol. 2017 Feb;13(2):149-156
pubmed: 27635473
Rev Physiol Biochem Pharmacol. 2022;183:45-101
pubmed: 32715321
Carcinogenesis. 2015 Mar;36(3):355-67
pubmed: 25653233
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cell Cycle. 2010 Aug 1;9(15):3022-9
pubmed: 20699664
Lancet. 1989 Jan 28;1(8631):188-91
pubmed: 2563099
Anticancer Res. 2012 Jan;32(1):351-7
pubmed: 22213326
Breast Cancer (Auckl). 2017 Dec 20;11:1178223417749816
pubmed: 29434472
J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62
pubmed: 16288118
Breast Care (Basel). 2020 Jun;15(3):217-226
pubmed: 32774215
Endocrinology. 2010 Jan;151(1):32-42
pubmed: 19906814
Cancer Metab. 2018 Aug 30;6:11
pubmed: 30181873
Braz J Med Biol Res. 2002 Jan;35(1):1-9
pubmed: 11743608
Cancer Res. 1993 Jun 1;53(11):2534-7
pubmed: 8495416
Semin Oncol. 2003 Oct;30(5 Suppl 16):14-20
pubmed: 14613022
Exp Cell Res. 2000 Jul 10;258(1):101-8
pubmed: 10912792
Cancer Res. 1993 Mar 15;53(6):1328-31
pubmed: 8443813
Can J Physiol Pharmacol. 2020 Aug;98(8):548-556
pubmed: 32762631
J Clin Oncol. 2008 Mar 1;26(7):1051-7
pubmed: 18309940
Breast Cancer Res Treat. 2013 May;139(1):95-105
pubmed: 23580071
Oncol Rep. 2000 Jan-Feb;7(1):169-70
pubmed: 10601612
J Steroid Biochem Mol Biol. 2002 Feb;80(2):239-56
pubmed: 11897507
Rev Endocr Metab Disord. 2012 Mar;13(1):45-55
pubmed: 21870057
Clin Endocrinol (Oxf). 1980 Sep;13(3):267-72
pubmed: 6260398
Endocrinology. 1995 Feb;136(2):812-5
pubmed: 7835315
J Cell Biochem. 1999 Dec 15;75(4):640-51
pubmed: 10572247
Cancer Res. 2007 Apr 15;67(8):3853-61
pubmed: 17440100
Anticancer Res. 2011 Sep;31(9):2939-48
pubmed: 21868542
J Allergy Clin Immunol. 2014 May;133(5):1356-64, 1364.e1-14
pubmed: 24461581
Antioxid Redox Signal. 2001 Dec;3(6):969-79
pubmed: 11813992
Am J Cancer Res. 2017 Jul 01;7(7):1486-1500
pubmed: 28744399
Endocrinology. 2000 Oct;141(10):3657-67
pubmed: 11014220
J Steroid Biochem Mol Biol. 2015 Apr;148:148-55
pubmed: 25445919
Histochem J. 2002 Jan-Feb;34(1-2):35-40
pubmed: 12365798
Endocrine. 2007 Aug;32(1):69-78
pubmed: 17992604
J Biol Chem. 1994 Mar 25;269(12):8675-9
pubmed: 8132595
Endocr Relat Cancer. 2013 Jul 05;20(4):565-77
pubmed: 23744764
Cancer Lett. 2008 Oct 8;269(2):226-42
pubmed: 18492603
J Clin Pathol. 2018 Jan;71(1):34-39
pubmed: 28663327
J Steroid Biochem Mol Biol. 2017 Oct;173:122-129
pubmed: 27923595
J Biol Chem. 2001 Jul 13;276(28):26365-73
pubmed: 11331275
Altern Med Rev. 2003 Aug;8(3):303-18
pubmed: 12946240
J Immunol. 2001 Nov 1;167(9):4974-80
pubmed: 11673504
J Clin Oncol. 2006 Feb 1;24(4):675-80
pubmed: 16446340
J Steroid Biochem Mol Biol. 1996 Jul;58(4):395-401
pubmed: 8903423
J Mol Endocrinol. 2005 Aug;35(1):117-33
pubmed: 16087726
Bone Rep. 2018 Jun 13;9:110-119
pubmed: 30591928
Nutrients. 2015 Jun 19;7(6):5020-50
pubmed: 26102214
Front Immunol. 2013 Jun 18;4:148
pubmed: 23785369
J Steroid Biochem Mol Biol. 1993 Apr;45(4):257-63
pubmed: 8388708
Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E299-307
pubmed: 16219669
Blood. 1988 Aug;72(2):567-72
pubmed: 3165295
Expert Opin Drug Deliv. 2016 Jun;13(6):873-89
pubmed: 26981891
Cancer Res. 2000 Apr 1;60(7):2040-8
pubmed: 10766196
Breast Cancer Res Treat. 1994 Feb;29(2):161-8
pubmed: 8012034
Front Physiol. 2014 Apr 03;5:122
pubmed: 24772087
Anticancer Res. 2006 Jul-Aug;26(4A):2597-603
pubmed: 16886669
Cell Biol Int. 2017 Aug;41(8):890-897
pubmed: 28627723
Clin Breast Cancer. 2022 Jan;22(1):e80-e90
pubmed: 34312098
Clin Nutr. 2014 Feb;33(1):136-42
pubmed: 23623780
Genes Dev. 1996 Jan 15;10(2):142-53
pubmed: 8566748
Mol Cancer Ther. 2006 Nov;5(11):2786-97
pubmed: 17121925
Ther Drug Monit. 2015 Dec;37(6):733-44
pubmed: 25853922
Cancer Biol Ther. 2013 Jun;14(6):476-80
pubmed: 23760489
Sci Rep. 2020 Jan 30;10(1):1493
pubmed: 32001757
Am J Pathol. 2010 Jun;176(6):2911-20
pubmed: 20395444
Am J Med Sci. 1992 Sep;304(3):202-13
pubmed: 1335685
J Biol Chem. 2002 Jul 12;277(28):25125-32
pubmed: 11991950
Cancer Res. 2005 Aug 1;65(15):6934-42
pubmed: 16061678
Breast Cancer Res Treat. 2010 Jan;119(1):111-8
pubmed: 19655244
Int J Oncol. 2018 Jan;52(1):103-126
pubmed: 29115583
Endocr Rev. 2016 Oct;37(5):521-547
pubmed: 27588937
Med Hypotheses. 2018 Sep;118:36-41
pubmed: 30037612
Kidney Int. 1998 Nov;54(5):1463-9
pubmed: 9844122
J Oncol. 2010;2010:
pubmed: 20871846
Anticancer Res. 2005 Nov-Dec;25(6B):4333-9
pubmed: 16309237
Curr Cancer Drug Targets. 2004 May;4(3):285-98
pubmed: 15134535
Circ Res. 2000 Aug 4;87(3):214-20
pubmed: 10926872
Eur J Pharm Sci. 2013 Feb 14;48(3):416-27
pubmed: 23262059
Epidemiology. 2000 Jul;11(4):376-81
pubmed: 10874542
Cancer Lett. 2004 Nov 8;215(1):1-20
pubmed: 15374627
J Steroid Biochem Mol Biol. 2004 Dec;92(5):365-74
pubmed: 15698541
N Engl J Med. 1992 Mar 26;326(13):852-6
pubmed: 1542321
Neurochirurgie. 2015 Apr-Jun;61(2-3):77-84
pubmed: 25908646
Mol Aspects Med. 2015 Feb;41:1-115
pubmed: 25543955
Cancers (Basel). 2020 May 29;12(6):
pubmed: 32486021
Mol Cancer. 2013 Feb 04;12:9
pubmed: 23379261
Endocrinology. 2012 Jun;153(6):2576-87
pubmed: 22454149
Int J Mol Sci. 2012 Dec 20;14(1):108-45
pubmed: 23344024
Mol Cancer Ther. 2015 Aug;14(8):1951-61
pubmed: 25934710
Breast Cancer Res Treat. 1997 Jan;42(1):31-41
pubmed: 9116316
J Pineal Res. 2009 Mar;46(2):172-80
pubmed: 19175854
J Control Release. 2012 Apr 10;159(1):14-26
pubmed: 22154931
Saudi Pharm J. 2021 Jul;29(7):656-669
pubmed: 34400859
Breast Cancer Res Treat. 1999 Jan;53(2):113-20
pubmed: 10326788
Biochem Pharmacol. 1992 Aug 18;44(4):693-702
pubmed: 1324683
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):372-5
pubmed: 20398752
Clin Cancer Res. 2007 Feb 15;13(4):1216-23
pubmed: 17317832
Horm Cancer. 2011 Jun;2(3):190-202
pubmed: 21686077
J Nanosci Nanotechnol. 2012 Mar;12(3):2185-91
pubmed: 22755036
Oncogene. 2003 Jul 24;22(30):4702-9
pubmed: 12879015
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Nutr Cancer. 2001;41(1-2):135-44
pubmed: 12094616
Cancer. 2001 Jun 15;91(12):2431-9
pubmed: 11413535
J Biomed Sci. 2017 Dec 04;24(1):90
pubmed: 29202842
Biochim Biophys Acta. 2013 Jan;1833(1):40-7
pubmed: 23085504
J Pineal Res. 1993 May;14(4):151-68
pubmed: 8102180
Mol Med Rep. 2017 Jan;15(1):467-473
pubmed: 27922682
Int J Mol Sci. 2013 Jul 26;14(8):15655-68
pubmed: 23896596
Int J Cancer. 2006 Jun 15;118(12):3012-21
pubmed: 16395705
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Endocr Relat Cancer. 2010 Jan 29;17(1):R19-38
pubmed: 19926709
Horm Cancer. 2011 Oct;2(5):272-85
pubmed: 21887591
Clin Endocrinol (Oxf). 2018 Sep;89(3):280-296
pubmed: 29741296
Cells. 2019 Jul 05;8(7):
pubmed: 31284489
Ann Oncol. 2008 Aug;19(8):1407-1416
pubmed: 18448451
Breast Cancer Res. 2005;7(6):R980-6
pubmed: 16280049
Int J Oncol. 2018 Feb;52(2):337-366
pubmed: 29345296
BMC Cancer. 2014 Oct 03;14:745
pubmed: 25280486
Immunopharmacol Immunotoxicol. 2011 Jun;33(2):241-9
pubmed: 20929432
Br J Cancer. 1983 Nov;48(5):689-96
pubmed: 6416285
Ultrasonography. 2016 Oct;35(4):281-8
pubmed: 27599892
Biomed Pharmacother. 2017 Oct;94:21-26
pubmed: 28750356
Int J Mol Sci. 2016 Jul 05;17(7):
pubmed: 27399677
Endocrinology. 2016 Oct;157(10):4066-4075
pubmed: 27526034
Endocr Rev. 2004 Feb;25(1):45-71
pubmed: 14769827
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):343-8
pubmed: 20156557
Ann N Y Acad Sci. 2002 May;957:210-29
pubmed: 12074974
Molecules. 2019 Mar 21;24(6):
pubmed: 30901941
Cancer Chemother Pharmacol. 2007 Apr;59(5):581-7
pubmed: 17066293
J Steroid Biochem Mol Biol. 2021 Nov;214:105979
pubmed: 34438041
J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):149-57
pubmed: 12710998
J Magn Reson Imaging. 2017 Oct;46(4):1017-1027
pubmed: 28177554
Front Immunol. 2018 Aug 13;9:1873
pubmed: 30150993
Clin Cancer Res. 1999 Jun;5(6):1339-45
pubmed: 10389917
J Cell Physiol. 2009 Sep;220(3):593-9
pubmed: 19373868
Anticancer Res. 2011 Dec;31(12):4359-67
pubmed: 22199301
Signal Transduct Target Ther. 2019 Dec 17;4:62
pubmed: 31871779
Nat Genet. 2000 Jun;25(2):144-6
pubmed: 10835626
Front Nutr. 2021 Apr 01;8:655727
pubmed: 33869269
Support Care Cancer. 2019 Apr;27(4):1325-1334
pubmed: 30729333
Anticancer Res. 2020 Feb;40(2):837-840
pubmed: 32014926
Breast Cancer Res. 2019 Jul 29;21(1):84
pubmed: 31358030
Cancer Chemother Pharmacol. 2009 Dec;65(1):33-40
pubmed: 19396601
Endocrinology. 1998 Apr;139(4):2102-10
pubmed: 9528999
Cancer Res. 1994 Nov 1;54(21):5711-7
pubmed: 7923220
Adv Healthc Mater. 2020 Jun;9(12):e2000392
pubmed: 32419319
Cell Immunol. 2019 Sep;343:103753
pubmed: 29395859
Oncogene. 1999 Dec 20;18(55):7908-16
pubmed: 10630643
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4192-9
pubmed: 14507860
Br J Cancer. 1989 Feb;59(2):268-75
pubmed: 2930691
Life Sci. 2017 Mar 1;172:27-41
pubmed: 27986539
Int J Mol Sci. 2021 Mar 09;22(5):
pubmed: 33803480
J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):181-92
pubmed: 12711002
Endocrinology. 1991 Aug;129(2):832-7
pubmed: 1855478
Eur J Cancer. 2014 May;50(8):1403-11
pubmed: 24703104
J BUON. 2019 Mar-Apr;24(2):862
pubmed: 31128048
Exp Cell Res. 2010 Feb 1;316(3):433-42
pubmed: 19932096
Zhongguo Dang Dai Er Ke Za Zhi. 2008 Feb;10(1):55-9
pubmed: 18289473
Endocr J. 2013;60(2):167-72
pubmed: 23064476
Radiother Oncol. 2009 Sep;92(3):323-8
pubmed: 19541381
J Biol Chem. 2011 Oct 21;286(42):36228-37
pubmed: 21868377
Cancer Res. 1996 Jan 15;56(2):264-7
pubmed: 8542578
Am J Clin Nutr. 2004 Dec;80(6 Suppl):1721S-4S
pubmed: 15585794
Br J Cancer. 2005 Aug;93 Suppl 1:S1-5
pubmed: 16100519
Anticancer Drugs. 1995 Aug;6(4):562-9
pubmed: 7579560
Oncology (Williston Park). 2006 Aug;20(9):1029-39; discussion 1039-40, 1042, 1048
pubmed: 16986348
Cancers (Basel). 2019 Nov 06;11(11):
pubmed: 31698751
Cancer Res. 1994 Apr 1;54(7):1653-6
pubmed: 8137276
Cancer. 2006 May 15;106(10):2136-42
pubmed: 16598750
Annu Rev Pharmacol Toxicol. 2011;51:311-36
pubmed: 20936945
J Steroid Biochem Mol Biol. 2015 Apr;148:122-31
pubmed: 25510900
Adv Nutr. 2015 Jul 15;6(4):408-19
pubmed: 26178025
Mol Cell Endocrinol. 2017 Sep 15;453:36-45
pubmed: 28400273
J Pineal Res. 2011 Mar;50(2):150-8
pubmed: 21091766
Cell Commun Signal. 2020 Aug 17;18(1):128
pubmed: 32807176
J Immunol. 2014 Oct 1;193(7):3456-62
pubmed: 25149465
Adv Prostaglandin Thromboxane Leukot Res. 1983;12:299-302
pubmed: 6221606
Clin Pharmacol Ther. 2002 Dec;72(6):648-59
pubmed: 12496746
CA Cancer J Clin. 2011 May-Jun;61(3):139-56
pubmed: 21543824
Cancer Prev Res (Phila). 2008 Nov;1(6):476-84
pubmed: 19138995
Clin Cancer Res. 2000 Aug;6(8):3371-9
pubmed: 10955825

Auteurs

Mariana Segovia-Mendoza (M)

Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.

Janice García-Quiroz (J)

Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico.

Lorenza Díaz (L)

Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico.

Rocío García-Becerra (R)

Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH